These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 22841133)

  • 21. Successful desensitization to 6-mercaptopurine in a patient with Crohn's disease.
    Mutinga M; Castells M; Horan R; Farraye FA
    Am J Gastroenterol; 2000 May; 95(5):1383-4. PubMed ID: 10811376
    [No Abstract]   [Full Text] [Related]  

  • 22. Hepatotoxicity of 6-mercaptopurine in Crohn's disease.
    Gross R; Scapa E
    Am J Gastroenterol; 1992 Dec; 87(12):1885-6. PubMed ID: 1449165
    [No Abstract]   [Full Text] [Related]  

  • 23. Adverse events of thiopurine immunomodulators in patients with inflammatory bowel disease.
    López-Martín C; Chaparro M; Espinosa L; Bejerano A; Maté J; Gisbert JP
    Gastroenterol Hepatol; 2011; 34(6):385-92. PubMed ID: 21616565
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ITPA genotyping test does not improve detection of Crohn's disease patients at risk of azathioprine/6-mercaptopurine induced myelosuppression.
    Allorge D; Hamdan R; Broly F; Libersa C; Colombel JF
    Gut; 2005 Apr; 54(4):565. PubMed ID: 15753546
    [No Abstract]   [Full Text] [Related]  

  • 25. Hepatoportal sclerosis: CT and MRI appearance with histopathologic correlation.
    Krishnan P; Fiel MI; Rosenkrantz AB; Hajdu CH; Schiano TD; Oyfe I; Taouli B
    AJR Am J Roentgenol; 2012 Feb; 198(2):370-6. PubMed ID: 22268180
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An unusual presentation of T-lymphoma in a Crohn's disease patient treated with combo therapy: we are willing to take a risk of serious adverse events for a doubtful benefit?
    Sinagra E; Romano C; Virdone R; Orlando E; Cottone M; Orlando A
    J Crohns Colitis; 2012 Oct; 6(9):954-5. PubMed ID: 22771136
    [No Abstract]   [Full Text] [Related]  

  • 27. Clinical predictors of thiopurine-related adverse events in Crohn's disease.
    Moran GW; Dubeau MF; Kaplan GG; Yang H; Eksteen B; Ghosh S; Panaccione R
    World J Gastroenterol; 2015 Jul; 21(25):7795-804. PubMed ID: 26167079
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 6-Mercaptopurine/Azathioprine remains an important contributor in managing Crohn's disease.
    Korelitz BI; Present DH
    J Crohns Colitis; 2014 Aug; 8(8):735-8. PubMed ID: 24462321
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunosuppression in patients with Crohn's disease and neoplasia: an ongoing clinical dilemma.
    Dasari BV; McBrearty A; Gardiner K
    Dis Colon Rectum; 2012 Sep; 55(9):1008-11. PubMed ID: 22874610
    [No Abstract]   [Full Text] [Related]  

  • 30. Nocardia pneumonia in a patient with Crohn's disease receiving 6-mercaptopurine and infliximab.
    Saleemuddin A; Govender P; Farraye FA
    J Crohns Colitis; 2014 Jul; 8(7):708-9. PubMed ID: 24342764
    [No Abstract]   [Full Text] [Related]  

  • 31. Therapeutic efficacy and safety of 6-mercaptopurine and azathioprine in patients with Crohn's disease.
    Markowitz JF
    Rev Gastroenterol Disord; 2003; 3 Suppl 1():S23-9. PubMed ID: 12684586
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The debated role for thiopurines in Crohn's disease.
    Herrlinger KR; Stange EF
    J Crohns Colitis; 2014 Feb; 8(2):172-4. PubMed ID: 24342765
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatoportal sclerosis as a cause of noncirrhotic portal hypertension in patients with HIV.
    Schiano TD; Kotler DP; Ferran E; Fiel MI
    Am J Gastroenterol; 2007 Nov; 102(11):2536-40. PubMed ID: 17640321
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thiopurine-induced pancreatitis in inflammatory bowel diseases.
    Ledder O; Lemberg DA; Day AS
    Expert Rev Gastroenterol Hepatol; 2015 Apr; 9(4):399-403. PubMed ID: 25494551
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nodular regenerative hyperplasia of the liver secondary to azathioprine in a patient with inflammatory bowel disease.
    Bryant DL; Miles CJ; Gearry RB
    N Z Med J; 2010 Apr; 123(1313):74-6. PubMed ID: 20581898
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recent advances using immunomodulators for inflammatory bowel disease.
    Nielsen OH; Bjerrum JT; Herfarth H; Rogler G
    J Clin Pharmacol; 2013 Jun; 53(6):575-88. PubMed ID: 23408468
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The pharmacokinetic effect of adalimumab on thiopurine metabolism in Crohn's disease patients.
    Wong DR; Pierik M; Seinen ML; van Bodegraven AA; Gilissen LP; Bus P; Bakker JA; Masclee AA; Neef C; Engels LG; Hooymans PM
    J Crohns Colitis; 2014 Feb; 8(2):120-8. PubMed ID: 23932783
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
    Caprilli R; Angelucci E; Cocco A; Viscido A; Annese V; Ardizzone S; Biancone L; Castiglione F; Cottone M; Meucci G; Paoluzi P; Papi C; Sturniolo GC; Vecchi M
    Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Successful Mercaptopurine Usage despite Azathioprine-Induced Pancreatitis in Paediatric Crohn's Disease.
    Gallego-Gutiérrez S; Navas-López VM; Kolorz M; Bartosova L; Lukac K; Luque-Pérez S; Núñez-Caro L; García-Galán P; Fernández-Crehuet FG; Blasco-Alonso J; Serrano-Nieto MJ; Sierra-Salinas C
    J Crohns Colitis; 2015 Aug; 9(8):676-9. PubMed ID: 25968582
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Azathioprine or mercaptopurine-induced acute pancreatitis is not a disease-specific phenomenon.
    van Geenen EJ; de Boer NK; Stassen P; Linskens RK; Bruno MJ; Mulder CJ; Stegeman CA; van Bodegraven AA
    Aliment Pharmacol Ther; 2010 Jun; 31(12):1322-9. PubMed ID: 20222913
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.